PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 178 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $683,505 | -32.8% | 30,500 | +22.0% | 0.01% | -23.5% |
Q2 2023 | $1,016,750 | -26.4% | 25,000 | -12.3% | 0.02% | -41.4% |
Q1 2023 | $1,380,540 | +20.6% | 28,500 | -5.0% | 0.03% | +7.4% |
Q4 2022 | $1,145,100 | +14.1% | 30,000 | +50.0% | 0.03% | +12.5% |
Q3 2022 | $1,004,000 | -37.3% | 20,000 | -50.0% | 0.02% | -42.9% |
Q2 2022 | $1,602,000 | +7.4% | 40,000 | 0.0% | 0.04% | +10.5% |
Q1 2022 | $1,492,000 | -6.3% | 40,000 | 0.0% | 0.04% | +18.8% |
Q4 2021 | $1,593,000 | +7.1% | 40,000 | 0.0% | 0.03% | +39.1% |
Q3 2021 | $1,488,000 | -12.0% | 40,000 | 0.0% | 0.02% | -4.2% |
Q2 2021 | $1,691,000 | -10.7% | 40,000 | 0.0% | 0.02% | 0.0% |
Q1 2021 | $1,894,000 | -25.3% | 40,000 | -3.8% | 0.02% | -14.3% |
Q4 2020 | $2,537,000 | +8.5% | 41,572 | -16.9% | 0.03% | -37.8% |
Q3 2020 | $2,338,000 | +15.2% | 50,000 | +25.0% | 0.04% | -18.2% |
Q2 2020 | $2,030,000 | +13.8% | 40,000 | 0.0% | 0.06% | -25.7% |
Q1 2020 | $1,784,000 | -82.4% | 40,000 | -81.0% | 0.07% | -77.6% |
Q4 2019 | $10,116,000 | +25.4% | 210,611 | -11.7% | 0.33% | +2.8% |
Q3 2019 | $8,065,000 | -5.7% | 238,455 | +25.4% | 0.32% | +59.4% |
Q2 2019 | $8,555,000 | +127.3% | 190,118 | +90.1% | 0.20% | +74.1% |
Q1 2019 | $3,764,000 | +21.9% | 100,000 | +11.1% | 0.12% | -4.9% |
Q4 2018 | $3,089,000 | -34.3% | 90,000 | -10.0% | 0.12% | +20.8% |
Q3 2018 | $4,700,000 | +39.3% | 100,000 | 0.0% | 0.10% | +23.2% |
Q2 2018 | $3,373,000 | -28.8% | 100,000 | -42.9% | 0.08% | -13.7% |
Q1 2018 | $4,736,000 | +467.9% | 175,000 | +250.0% | 0.10% | +533.3% |
Q4 2017 | $834,000 | -16.7% | 50,000 | 0.0% | 0.02% | -21.1% |
Q3 2017 | $1,001,000 | -45.4% | 50,000 | -50.0% | 0.02% | -66.1% |
Q2 2017 | $1,833,000 | +86.3% | 100,000 | 0.0% | 0.06% | +107.4% |
Q1 2017 | $984,000 | +80.2% | 100,000 | +100.0% | 0.03% | +50.0% |
Q4 2016 | $546,000 | -61.0% | 50,000 | -50.0% | 0.02% | -62.5% |
Q3 2016 | $1,401,000 | -68.7% | 100,000 | +7.5% | 0.05% | -50.5% |
Q2 2015 | $4,477,000 | +267.9% | 93,000 | +365.0% | 0.10% | +259.3% |
Q1 2015 | $1,217,000 | – | 20,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |